PTEN and central nervous system cancer: A well-documented alteration in GBM is amplification and activating mutation (EGFRVIII) of EGFR. TCGA analysis of gliomas shows this mutation to be frequently associated with PTEN loss and to be the signature lesion of the EGFR subset of GBMs [9], [11].